Randomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, Blinatumomab and SCT (GMALL-EVOLVE)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT06061094 |
|
Recruitment Status :
Recruiting
First Posted : September 29, 2023
Last Update Posted : May 6, 2024
|
Sponsor:
Goethe University
Collaborators:
Deutsche Leukämie- & Lymphom-Hilfe
German Federal Ministry of Education and Research
Information provided by (Responsible Party):
Nicola Goekbuget, Goethe University
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | July 1, 2029 |
| Estimated Study Completion Date : | July 1, 2029 |